Results 11 to 20 of about 27,602 (209)

Utilizing enoxaparin in the management of STEMI

Vascular Health and Risk Management, 2007
Andrea Rubboli1, Alessandro Capecchi2, Giuseppe Di Pasquale11Division of Cardiology, Maggiore Hospital, Bologna, Italy; 2Division of Cardiology, General Hospital, Bentivoglio, ItalyAbstract: The use of enoxaparin in conjunction with thrombolysis in ST ...
Alessandro Capecchi, Giuseppe Di Pasquale, Andrea Rubboli   +2 more
core   +1 more source

Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications

Clinical Pharmacology: Advances and Applications, 2018
Linda Tahaineh,1 Sahar M Edaily,1 Shadi F Gharaibeh2 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology (JUST), Irbid, Jordan; 2Department of Pharmaceutical Sciences, Faculty of Pharmacy, Jerash University,
Tahaineh L, Edaily SM, Gharaibeh SF
core   +1 more source

Update on the Pharmacological Actions of Enoxaparin in Nonsurgical Patients

Medicina
Low-molecular-weight heparins are a class of drugs derived from the enzymatic depolymerization of unfractionated heparin that includes enoxaparin. Several studies have been performed on enoxaparin in recent years, in particular for the prevention and ...
Dattilo, Giuseppe, Alessandro Perrella, Marianna Gigliotti De Fazio, Vincenzo Russo, Francesca Futura Bernardi, Gigliotti De Fazio, Marianna, Giuseppe Camporese, Giuseppe Dattilo, Imbalzano, Egidio, Orlando, Luana, Russo, Vincenzo, Perrella, Alessandro, Di Micco, Pierpaolo, Luana Orlando, Camporese, Giuseppe, Pierpaolo Di Micco, Egidio Imbalzano, Bernardi, Francesca Futura   +17 more
core   +2 more sources

Effects of Enoxaparin Emulsion on Dimethylbenzanthracene-induced Breast Cancer in Female Rats

Research in Molecular Medicine, 2017
Background : Enoxaparin is an anticoagulant medication. Anticoagulation inhibits tumor cell–mediated release of angiogenic proteins and diminishes angiogenic response.
Mousavi, Moona Bolandpayeh, Hassanpour-Ezzati   +2 more
core   +1 more source

Enoxaparin pretreatment alleviates pentylenetetrazol-induced epileptic seizures in Wistar rats

Revista Científica
Epilepsy, is a prevalent neurological disorder characterized by recurring seizures. A low molecular weight heparin enoxaparin has multifaceted properties.
Gungor, Huseyin, Turgut, Nergiz Hacer, Turgut, NH, Gungor, H   +3 more
core   +2 more sources

Biosimilar versus branded enoxaparin to prevent postoperative venous thromboembolism after surgery for digestive tract cancer: Randomized trial.

PLoS ONE, 2023
Cancer and/or major surgery are two factors that predispose to post-operative thrombosis. The annual incidence of venous thromboembolic disease (VTED) in cancer patients was estimated at 0.5%-20%.
Chadli Dziri, Wafa Ben Hmida, Wejih Dougaz, Mehdi Khalfallah, Imen Samaali, Hichem Jerraya, Ibtissem Bouasker, Ramzi Nouira   +7 more
doaj   +1 more source

Admission thrombelastography does not guide dose adjustment of enoxaparin in trauma patients

Surgery Open Science, 2020
Background: Enoxaparin is used as chemoprophylaxis to reduce incidence of venous thromboembolism and its complications following trauma. Serum anti-Xa monitoring is used to assess efficacy but requires several doses to be administered. Thrombelastography
Hannah V. Hayes, Molly E. Droege, Craig J. Furnish, Michael D. Goodman, Neil E. Ernst, Christopher A. Droege   +5 more
doaj   +1 more source

The effects of enoxaparin on the liver in experimental pneumoperitoneum model [PDF]

Acta Cirúrgica Brasileira, 2016
PURPOSE: To investigate the potential protective effects of enoxaparin against the adverse events of carbon dioxide (CO2) pneumoperitoneum. METHODS: Thirty four rats were divided into three groups: Group 1 (sham) underwent insertion of Veress needle ...
Turgut Cavusoglu, Kemal Kismet, Namik Ozcan, Berkay Kucuk, Aziz Mutlu Barlas, Bahadir Osman Bozkirli, Pinar Celepli, Mehmet Senes, Serkan Bolat, Sema Hucumenoglu   +9 more
doaj   +2 more sources

The Impact of Continuous Veno-Venous Hemodiafiltration on the Efficacy of Administration of Prophylactic Doses of Enoxaparin: A Prospective Observational Study

Pharmaceuticals, 2023
Background: Critically ill patients frequently require continuous renal replacement therapy (CRRT). During CRRT, particles up to 10 kDa in size, such as enoxaparin, may be removed. The aim of this study was to determine if patients receiving prophylactic
Aleksander Aszkiełowicz, Karol P. Steckiewicz, Michał Okrągły, Magdalena A. Wujtewicz, Radosław Owczuk   +4 more
doaj   +1 more source

Cell-Penetrating Peptide-Surface Modified Liposomes to Enhance the Intestinal Absorption of Enoxaparin [PDF]

Pharmaceutical Sciences, 2023
Background: Enoxaparin is low-molecular-weight heparin administered by subcutaneous/intravenous injection. The oral bioavailability of enoxaparin is restricted by its low absorption through the intestine.
Hessam Rostamian, Hadi Valizadeh, Mohammad Mahmoudian, Ziba Islambulchilar, Parvin Zakeri-Milani   +4 more
doaj   +1 more source